European Commission Approves Pfizer's HYMPAVZI™ (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without InhibitorsBusiness Wire • 11/20/24
If I Could Only Buy 2 High Dividend Yield Companies In November 2024: Both Yield Above 6%Seeking Alpha • 11/19/24
These 4 Price-to-Sales Stocks Can Supercharge Your Portfolio GrowthZacks Investment Research • 11/19/24
Buy 5 U.S. Bigwigs on the Dip for Sparkling Returns in the Short TermZacks Investment Research • 11/18/24
Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretaryFast Company • 11/15/24
Vaccine maker stocks fall after conspiracy theory-spreading RFK Jr. tapped to lead health departmentNew York Post • 11/15/24
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHSInvestors Business Daily • 11/15/24
Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHSMarket Watch • 11/14/24
Down -11.04% in 4 Weeks, Here's Why You Should You Buy the Dip in Pfizer (PFE)Zacks Investment Research • 11/13/24